1. Home
  2. XBIT vs CBAT Comparison

XBIT vs CBAT Comparison

Compare XBIT & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.41

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Logo CBAK Energy Technology Inc.

CBAT

CBAK Energy Technology Inc.

HOLD

Current Price

$0.86

Market Cap

71.5M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
CBAT
Founded
2005
1999
Country
United States
China
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
71.3M
71.5M
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
XBIT
CBAT
Price
$2.41
$0.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
37.6K
179.7K
Earning Date
03-13-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
533.33
EPS
N/A
N/A
Revenue
N/A
$176,614,609.00
Revenue This Year
N/A
$16.06
Revenue Next Year
N/A
$70.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$0.57
52 Week High
$3.62
$1.25

Technical Indicators

Market Signals
Indicator
XBIT
CBAT
Relative Strength Index (RSI) 54.01 30.43
Support Level $2.32 $0.84
Resistance Level $2.49 $0.93
Average True Range (ATR) 0.10 0.06
MACD 0.00 -0.02
Stochastic Oscillator 75.94 9.33

Price Performance

Historical Comparison
XBIT
CBAT

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.

Share on Social Networks: